niacinamide has been researched along with Adenocarcinoma of Lung in 6 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| " One patient with advanced-stage lung adenocarcinoma, who was treated with oral sorafenib, demonstrated a near-complete clinical and radiographic remission for 5 years." | 7.80 | Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma. ( Amann, J; Araujo, L; Carbone, DP; Greulich, H; Horn, L; Imielinski, M; Kaplan, B; Meyerson, M; Schiller, J; Villalona-Calero, MA, 2014) |
| "The aim of the present study was to observe the effects of sorafenib on the proliferation, apoptosis and invasion of A549/DDP cisplatin-resistant lung adenocarcinoma cells cultured in vitro." | 7.80 | Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro. ( Chen, XQ; Li, ZY; Lin, TY; Wang, YL, 2014) |
| " One patient with advanced-stage lung adenocarcinoma, who was treated with oral sorafenib, demonstrated a near-complete clinical and radiographic remission for 5 years." | 3.80 | Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma. ( Amann, J; Araujo, L; Carbone, DP; Greulich, H; Horn, L; Imielinski, M; Kaplan, B; Meyerson, M; Schiller, J; Villalona-Calero, MA, 2014) |
| "The aim of the present study was to observe the effects of sorafenib on the proliferation, apoptosis and invasion of A549/DDP cisplatin-resistant lung adenocarcinoma cells cultured in vitro." | 3.80 | Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro. ( Chen, XQ; Li, ZY; Lin, TY; Wang, YL, 2014) |
| "Brain metastases are a common consequence of advanced lung cancer, resulting in cranial neuropathies and increased mortality." | 1.51 | A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain Metastasis. ( Hoj, JP; Mayro, B; Pendergast, AM, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoj, JP | 1 |
| Mayro, B | 1 |
| Pendergast, AM | 1 |
| Wang, M | 1 |
| Naganna, N | 1 |
| Sintim, HO | 1 |
| Imielinski, M | 1 |
| Greulich, H | 1 |
| Kaplan, B | 1 |
| Araujo, L | 1 |
| Amann, J | 1 |
| Horn, L | 1 |
| Schiller, J | 1 |
| Villalona-Calero, MA | 1 |
| Meyerson, M | 1 |
| Carbone, DP | 1 |
| Masri, SC | 1 |
| Misselt, AJ | 1 |
| Dudek, A | 1 |
| Konety, SH | 1 |
| Chen, XQ | 1 |
| Wang, YL | 1 |
| Li, ZY | 1 |
| Lin, TY | 1 |
| Morgillo, F | 1 |
| Cascone, T | 1 |
| D'Aiuto, E | 1 |
| Martinelli, E | 1 |
| Troiani, T | 1 |
| Saintigny, P | 1 |
| De Palma, R | 1 |
| Heymach, JV | 1 |
| Berrino, L | 1 |
| Tuccillo, C | 1 |
| Ciardiello, F | 1 |
6 other studies available for niacinamide and Adenocarcinoma of Lung
| Article | Year |
|---|---|
A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain Metastasis.
Topics: Acyltransferases; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Axl Receptor Tyrosine Kina | 2019 |
Identification of nicotinamide aminonaphthyridine compounds as potent RET kinase inhibitors and antitumor activities against RET rearranged lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; Dos | 2019 |
Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Amino Acid Substitution; Antineoplastic Agents; Cell T | 2014 |
Radiation recall reaction causing cardiotoxicity.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Chemoradiotherapy; Coronary Angiograp | 2014 |
Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Mov | 2014 |
Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Benzenesulfonates; Cell Line, Tumor; Cell Prolifera | 2011 |